Healthcare: Neurology

Parkinson's Disease and Movement Disorders

Media Component

The Parkinson's Disease Center and Movement Disorders Center at Baylor Medicine has long been recognized as one of the world's leading clinical and research institutions with primary focus on Parkinson's disease and other movement disorders.

The PDCMDC has been recognized as the Center of Excellence by the Parkinson’s Foundation, Tourette Association of America, and the Huntington's Disease Society of America.


Conditions We Treat


Movement disorders are a group of neurologic conditions characterized by slowness and paucity of movement (hypokinetic disorders) or abnormal excessive involuntary movements (hyperkinesias). While the brain basal ganglia and their connections have been implicated in most movement disorders, some are caused by other mechanisms. A subset of movement disorders with varied symptoms and signs are often caused by psychological factors, also known as functional disorders. We care for patients including, but not limited to the following conditions:


Why Choose Baylor Medicine?


Baylor Medicine excels in the diagnosis and treatment of neurodegenerative disorders such as Parkinson's disease as well as other movement disorders, emphasizing an individualized approach that helps each patient manage their symptoms and optimize their quality of life.

Patients benefit from:

  • Comprehensive and multidisciplinary clinical evaluation and treatment
  • An expert neurological staff specially trained in the recognition and treatment of movement disorders
  • A broad spectrum of treatment options, including conventional and experimental medications, botulinum toxin injections, and neurosurgery
  • Collaboration with the departments of Neurology, Neurosurgery, and Psychiatry to address the complex neurobehavioral problems associated with movement disorders
  • An emphasis on patient education
  • Access to the latest research findings and therapies

Clinical Trials


The best way to improve understanding of the cause of a disease and to develop new and approved treatments is through clinical research. Learn about PDCMDC clinical trials.